CONFERENCE REPORT Cancer Network presents exclusive coverage from the American Society of Hematology (ASH) annual meeting. We'll bring you onsite reports as we cover the latest research, trials, scientific advances, and controversies that are changing the way hematologic malignancies are managed and treated.
REVIEW ARTICLE Michael S. Mathisen, Elias Jabbour, Hagop M. Kantarjian;ONCOLOGY Vol. 26 No. 9 In this review, we will discuss the management of ALL in the adult population, in the context of the recently published guidelines from the NCCN. We will focus in particular on the strides being made in salvage and targeted approaches.
REVIEW ARTICLE Loretta J. Nastoupil, et al;ONCOLOGY Vol. 26 No. 5 This article examines clinical and biological features of DLBCL patients with poor outcomes, and reviews recent studies addressing alternatives to standard front-line management strategies together with unresolved questions.
REVIEW ARTICLE Bradford S. Hoppe, et al;ONCOLOGY Vol. 26 No. 5 This review addresses the rationale and evidence for—and the challenges, cost implications, and future development of—proton therapy as an important part of the treatment strategy in Hodgkin lymphoma.
A hematologically stable CML patient developed a solitary, exquisitely painful ulceration, 7 cm × 5 cm, located on the mid-medial foreleg. There was never any evidence of venous insufficiency. The patient denied the possibility of a spider bite. What is the likely cause of this lesion?
As an avid gardener, the patient spent considerable time outdoors and had never before experienced a similar problem. However, during the prior two spring-summer seasons. Almost every witnessed mosquito bite resulted in either a swollen, pruritic nodule or a substantial blister. This patient most likely has what underlying disease?
A 58-year-old man developed acute myeloid leukemia. After responding to remission-induction high-dose chemotherapy, he received an allogeneic stem cell transplant that was complicated by a graft-versus-host reaction. While being treated for the latter with prednisone, tacrolimus (Prograf), and mycophenolate mofetil (CellCept), he developed both fungal pneumonia and osteomyelitis caused by Fusarium species.
Five Steps to Improving Patient Access Judy Capko, May 21, 2013 Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.